KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, today ...

Chicago, IL – October 22, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks ...

SBI Securities has recommended buying shares of Coal India, Macrotech Developers, Bharti Hexacom, Nippon Life India, Escorts ...

Global pharma major Lupin Limited (Lupin) announced the appointment of Claus Jepsen as president, global specialty. He brings ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

GSK has announced a £50m ($54.3m) investment in a partnership with the University of Cambridge to expedite R&D in ...

Earnings before interest, tax, depreciation, and amortisation (Ebitda) is likely to remain flat at Rs 3,698.7 crore on an ...

Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical ...

Hindustan Unilever (HUL)- the country's leading FMCG player will come up with its Q2 earnings on October 23, 2024 (Wednesday) ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

Equities research analysts at Zacks Research decreased their FY2025 earnings per share (EPS) estimates for GSK in a research report issued to clients and investors on Wednesday, October 16th. Zacks ...

The RespiriNTM project has received funding from the Innovative Health Initiative 2 Joint Undertaking (JU) under grant agreement No 853932. This Joined Undertaking receives support from the European ...